Ariosa Diagnostics Inc., IPO Research Information

Ariosa Diagnostics Inc., IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ariosa Diagnostics Inc.,, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ariosa Diagnostics Inc.,	AROS - NASDAQ	TBD	$0.00	$0.00	TBD
Underwriter(s): J.P. Morgan, Citigroup
Co-Manager(s): Leerink Partners, William Blair
Industry:
Filing(s): Filed 2014-03-25 Terms Added 2014-04-25 Re-Filed 2014-04-29

About Ariosa Diagnostics Inc., (adapted from Ariosa Diagnostics Inc., prospectus):
They are a global commercial-stage molecular diagnostics company focused on improving overall patient care by developing and delivering innovative, affordable and widely-accessible genetic testing.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AROS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.